Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (KCT0012727) titled 'Efficacy of an opioid-sparing analgesic strategy using Unafra (opiranserin) in patients undergoing open abdominal aortic surgery' on Oct. 1.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Samsung Medical Center
Condition:
Diseases of the circulatory system
Intervention:
Drug : The intervention group will receive a single intravenous infusion of opiranserin (Unafra), starting at surgical wound closure. Opiranserin 1,000 mg (100 mL) will be diluted with 4...